Joint Meeting of the

Nonprescription Drugs Advisory committee

and the

Pulmonary-Allergy Drugs Advisory Committee

 

January 24, 2006

 

Table of Contents

 

 

 

Tab A:             Office Director’s Background Memorandum

 

Tab B:             Federal Register notice for the final rule revising § 2.125

 

Tab C:            Regulatory History of the OTC Bronchodilator Monograph